Compounds > isoproterenol

isoproterenol and ketorolac

isoproterenol has been researched along with ketorolac in 10 studies

Research

Studies (10)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (30.00)	29.6817
2010's	6 (60.00)	24.3611
2020's	1 (10.00)	2.80

Authors

Authors	Studies
Topliss, JG; Yoshida, F	1
Baert, B; Beetens, J; Bodé, S; De Spiegeleer, B; Deconinck, E; Lambert, J; Slegers, G; Slodicka, M; Stoppie, P; Van Gele, M; Vander Heyden, Y	1
Lombardo, F; Obach, RS; Waters, NJ	1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V	1
Bellman, K; Knegtel, RM; Settimo, L	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Jones, LH; Nadanaciva, S; Rana, P; Will, Y	1
Eldridge, MW; Harrell, JW; Johansson, RE; Kellawan, JM; Limberg, JK; Peltonen, GL; Schrage, WG; Sebranek, JJ	1
Fujii, N; Kenny, GP; McNeely, BD	1
Carter, KJ; Eldridge, MW; Harrell, JW; Johansson, RE; Kellawan, JM; Limberg, JK; Peltonen, GL; Schrage, WG; Sebranek, JJ; Walker, BJ	1

Reviews

1 review(s) available for isoproterenol and ketorolac

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Other Studies

9 other study(ies) available for isoproterenol and ketorolac

Article	Year
QSAR model for drug human oral bioavailability. Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13 Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship	2000
Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds. Bioorganic & medicinal chemistry, 2007, Nov-15, Volume: 15, Issue:22 Topics: Anti-Inflammatory Agents; Cell Membrane Permeability; Cluster Analysis; Drug Evaluation, Preclinical; Humans; Models, Biological; Predictive Value of Tests; Quantitative Structure-Activity Relationship; Regression Analysis; Skin; Skin Absorption	2007
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
FDA-approved drug labeling for the study of drug-induced liver injury. Drug discovery today, 2011, Volume: 16, Issue:15-16 Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration	2011
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds. Pharmaceutical research, 2014, Volume: 31, Issue:4 Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation	2014
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships. Bioorganic & medicinal chemistry letters, 2016, 08-15, Volume: 26, Issue:16 Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone	2016
β-Adrenergic-mediated vasodilation in young men and women: cyclooxygenase restrains nitric oxide synthase. American journal of physiology. Heart and circulatory physiology, 2016, Mar-15, Volume: 310, Issue:6 Topics: Adrenergic beta-Agonists; Adult; Cyclooxygenase Inhibitors; Enzyme Inhibitors; Female; Forearm; Humans; Infusions, Intra-Arterial; Isoproterenol; Ketorolac; Male; Microcirculation; Nitric Oxide Synthase; omega-N-Methylarginine; Prostaglandin-Endoperoxide Synthases; Sex Factors; Ultrasonography, Doppler; Vasodilation	2016
Nitric oxide synthase and cyclooxygenase modulate β-adrenergic cutaneous vasodilatation and sweating in young men. The Journal of physiology, 2017, 02-15, Volume: 595, Issue:4 Topics: Adrenergic beta-Agonists; Adult; Capillaries; Cyclooxygenase Inhibitors; Humans; Isoproterenol; Ketorolac; Male; Nitric Oxide Synthase Type III; Nitroarginine; Prostaglandin-Endoperoxide Synthases; Receptors, Adrenergic, beta; Skin; Sweating; Vasodilation	2017
Preserved β-adrenergic-mediated vasodilation in skeletal muscle of young adults with obesity despite shifts in cyclooxygenase and nitric oxide synthase. American journal of physiology. Heart and circulatory physiology, 2022, 01-01, Volume: 322, Issue:1 Topics: Adrenergic beta-Agonists; Adult; Blood Vessels; Cyclooxygenase Inhibitors; Female; Humans; Isoproterenol; Ketorolac; Male; Muscle, Skeletal; Nitric Oxide Synthase Type III; Obesity; omega-N-Methylarginine; Prostaglandin-Endoperoxide Synthases; Receptors, Adrenergic, beta; Vasodilation	2022